Connect with us
The company has confirmed that, as a result of its commitment to R&D in oncology, it has achieved a success rate of 37% in its research, compared...
Novo Nordisk increased its profit by 42.5% in the first half of 2023, reaching 39,242 million Danish crowns (€5.26 million). The firm has decided to increase...
AbolerIS Pharma is a biopharmaceutical company focused on revolutionizing immunotherapy for autoimmune and inflammatory diseases. Through an innovative antibody therapy directed against the novel target CD45RC,...
Vertex is a global biotech company that invests in scientific innovation to create medicines for people with serious diseases. The company has multiple medications approved to...
The creation of the clinical trials unit arose to enhance and support all clinical research carried out within the framework of an early phase clinical trial...
The biotech sector is composed of 66 percent micro-enterprises, consisting of one to nine employees, and only 8 percent large structures, with more than 250 people....
Microviable Therapeutics emerged as a spin-off of Ipla-Csic in 2016, focused on the development of therapeutic technologies and products derived from microbiota. Technological development, together with the...
Currently, Cebiotex maintains a strategic alliance with the Catalan pharmaceutical company Prasfarma, a supplier of cell membranes. The biotechnology company uses the facilities of the pharmaceutical company...
Following various acquisitions, Bruker moved its headquarters to Billerica/Massachusetts (Greater Boston) several years ago. In 2022, more than 7,500 Bruker employees worldwide generated sales of just...
Boehringer Ingelheim has developed this new obesity drug with Zealand Pharma. Survodutide works by mimicking a gut hormone called glucagon-like peptide-1, which suppresses appetite and helps...